Structural insights into the G-protein subtype selectivity revealed by human sphingosine-1-phosphate receptor 3–G <sub>q</sub> complexes
Abstract
Sphingosine-1-phosphate (S1P) is one of the most extensively studied bioactive lipids that transduces signals via the S1P receptor (S1PR) family (S1PR1-5), a class of G-protein-coupled receptors (GPCRs), to regulate immune cell migration, vascular permeability, and pain modulation. However, the mechanism for achieving specificity in downstream signaling remains poorly understood. Here, we present cryogenic electron microscopic structures of the S1PR3-G αq complex bound to endogenous agonists: d18:1 S1P or d16:1 S1P. Both agonists shared the same binding pocket and binding mode despite the different signaling intensities of the S1PR3-G αq signal pathway. By comparing the structures of two agonist-bound complexes, combined with mutagenesis studies, we identified key amino acids, Phe119 3.33 and Arg136 3.50 , that play crucial roles in differential agonist recognition and receptor activation. Furthermore, structural comparisons with previously determined S1PR3-G αi complex or G-protein-free S1PR3 structures, along with mutagenesis analysis, revealed dynamic intracellular loop 2 conformations and specific amino acid interactions that contribute to G-protein selectivity. Notably, we identified amino acids at the 34.50 and 34.53 positions within ICL2 as critical for specific interactions with G proteins. These findings provide better understanding of the mechanism of GPCR activation and unique perspectives that can be applied to other class A GPCRs, leading to the possibility of optimized drug development.
Article Details
Journal Info
Proceedings of the National Academy of Sciences
National Academy of Sciences
Authors (13)
Momono Yamauchi
Department of Drug Discovery Medicine, Graduate School of Medicine, Kyoto University
Dohyun Im
Department of Cell Biology, Graduate School of Medicine, Kyoto University
Shintaro Maeda
Department of Drug Discovery Medicine, Graduate School of Medicine, Kyoto University
Tatsuya Ikuta
Graduate School of Pharmaceutical Sciences, Tohoku University, 6-3, Aoba, Aramaki, Aoba-ku, Sendai, Miyagi 980-8578, Japan
Masayasu Toyomoto
Department of Drug Discovery Medicine, Graduate School of Medicine, Kyoto University
Hidetsugu Asada
Department of Cell Biology, Graduate School of Medicine, Kyoto University
Yukihiko Sugita
Institute for Life and Medical Sciences, Kyoto University, Kyoto, Japan.
Jun-ichi Kishikawa
Faculty of Applied Biology, Kyoto Institute of Technology, Matsugasaki Hashikami-cho
Takeshi Noda
Institute for Life and Medical Sciences, Kyoto University, Kyoto, Japan.
Takayuki Kato
Institute for Protein Research, Osaka University
Asuka Inoue
So Iwata
Masatoshi Hagiwara
Department of Drug Discovery Medicine, Graduate School of Medicine, Kyoto University